Edexcel A-Level Biology: Modern Genetics, Gene Technology and Genomics — Complete Revision Guide (9BI0)

Modern Genetics is the topic that turned biology into a precision discipline. Once you can move fluently from gene structure through transcription and translation, understand how the same genome produces ~200 different cell types via regulated gene expression and epigenetic marks, and reason about PCR, recombinant DNA, gene therapy and genomics, you have the framework for the most modern Paper 1 and Paper 3 questions — and a good starting point for university molecular biology, biochemistry, and medicine.

This guide is a topic-by-topic walkthrough of Topic 8's gene-technology content. It covers gene structure and the genetic code, transcription, translation, gene expression and regulation, epigenetics and gene silencing, PCR and gel electrophoresis, recombinant DNA and genetic engineering, gene therapy and screening, genomics and bioinformatics, and the ethics of genetic technology. For each topic you will find core ideas, common pitfalls, a worked example, and a link into the LearningBro Modern Genetics, Gene Technology and Genomics course.

What the Edexcel 9BI0 Specification Covers

Edexcel A-Level Biology B (9BI0) is examined in three written papers. Topic 8 — Grey Matter — is examined directly on Paper 2 and synoptically on Paper 3.

Modern-genetics questions tend to fall into three styles: short recall on transcription/translation steps; calculations on PCR amplification, Hardy-Weinberg, herd-immunity thresholds; and extended-response questions on regulatory mechanisms or ethical analyses. The table below maps the main sub-topics to a typical paper weighting.

Sub-topic	Spec area	Typical paper weight
Gene structure and genetic code	Topic 8	4–6 marks
Transcription	Topic 8	4–6 marks
Translation	Topic 8	4–6 marks
Gene expression and regulation	Topic 8	6–10 marks
Epigenetics	Topic 8	4–6 marks
PCR and gel electrophoresis	Topic 8	4–6 marks
Recombinant DNA	Topic 8	6–8 marks
Gene therapy and screening	Topic 8	4–6 marks
Genomics and bioinformatics	Topic 8	4–6 marks
Ethics	Topic 8 / Paper 3	6–10 marks

These weights are estimates. What is reliable is that a transcription/translation question and a recombinant-DNA question appear on most papers.

Gene Structure and the Genetic Code

A gene is a length of DNA coding for a polypeptide or functional RNA. Eukaryotic genes have introns (non-coding) and exons (coding), with promoter and terminator regions flanking. The genetic code is the rule for translating nucleotide triplets (codons) into amino acids — 64 codons for 20 amino acids + 3 stop codons.

Key properties: universality (essentially all life uses the same code), degeneracy (multiple codons per amino acid — protective against point mutations), non-overlapping (each base in one codon only), commaless (no separators).

Worked example. The DNA template strand reads 5'-TAC-GGT-TTA-AAA-3'. Predict the mRNA sequence and the encoded peptide. mRNA reads 3'-AUG-CCA-AAU-UUU-5', so reading 5'→3' gives 5'-UUU-AAA-ACC-GUA-3' — but reverse-complement convention makes mRNA read off the template strand directly: AUG-CCA-AAU-UUU. Codons translate to Met-Pro-Asn-Phe via the genetic code.

A common pitfall is to confuse gene with allele (gene = locus + sequence; allele = variant). Another is to confuse mitochondrial DNA (circular, slightly different code — UGA codes for tryptophan in mitochondria, not stop) with nuclear DNA.

See the gene structure lesson for codon table and gene anatomy diagrams.

Transcription

Transcription synthesises an RNA copy of one strand of a gene. RNA polymerase binds the promoter upstream of the gene → DNA double helix locally unwinds → RNA polymerase synthesises a complementary RNA copy of the template (antisense) strand, building the mRNA in the 5'→3' direction. Terminator sequence ends transcription.

In eukaryotes, post-transcriptional modification of pre-mRNA: 5' cap (m7G) protects 5' end and recruits ribosome; 3' poly-A tail (~200 nt) protects against degradation; splicing removes introns and joins exons via the spliceosome. Alternative splicing allows multiple proteins from one gene — humans have ~20,000 genes but >100,000 proteins.

Worked example. Predict the consequence of a mutation in the spliceosome's snRNP particles. Splicing fails; introns remain in mature mRNA; translation produces aberrant proteins terminating prematurely at intron stop codons. Most mRNAs become non-functional; many cell types die. Consistent with experimental snRNP knockdowns and rare human spliceosomopathies (e.g. retinitis pigmentosa from PRPF mutations).

A common pitfall is to confuse template (antisense) and coding (sense) strands. Another is to think the 5' cap is added during transcription and the poly-A tail is encoded in the gene — neither is correct.

See the transcription lesson for cascade diagrams.

Translation

Translation synthesises a polypeptide from an mRNA template using the genetic code. Small ribosomal subunit binds mRNA at the 5' cap → scans for AUG start codon → large subunit assembles → initiator tRNA-Met in the P site → incoming tRNA arrives at the A site → ribosome catalyses peptide bond formation → translocation moves ribosome one codon → repeat → stop codon → release factor terminates.

The wobble rule allows a single tRNA to read multiple synonymous codons via flexible third-base pairing.

The ribosome is a ribozyme — the rRNA is catalytic, the proteins are structural. Multiple ribosomes can translate one mRNA simultaneously (polyribosome).

Worked example. Predict the effect of a mutation that changes the AUG start codon to GUG. AUG codes for methionine and serves as the start signal; GUG codes for valine and is not normally a start codon. Translation initiation fails (or starts at a downstream AUG, producing a truncated protein lacking the N-terminal residues). Many mutations affecting start codons cause severe phenotypes — e.g. β-thalassaemia in some haemoglobin gene variants.

A common pitfall is to confuse codon (mRNA) with anticodon (tRNA). Another is to think translation reads strictly one codon per tRNA — wobble pairing breaks this assumption.

See the translation lesson for ribosome cascade diagrams.

Gene Expression and Regulation

Gene regulation can occur at every step from chromatin accessibility to protein degradation. Transcription is the most common regulation point, but mRNA stability, translation efficiency, post-translational modification, and protein turnover all matter.

The lac operon is the canonical prokaryotic example. Repressor protein binds operator → blocks RNA polymerase. When lactose is present, allolactose binds repressor → repressor releases → transcription proceeds. Glucose independently lowers cAMP → CAP-cAMP cannot bind promoter → transcription weak even when lactose is present (catabolite repression). Net: maximum transcription only when lactose is HIGH AND glucose is LOW — an AND-gate.

Eukaryotic regulation uses transcription factors binding to enhancers and promoters, plus chromatin remodelling and alternative splicing.

Worked example. Predict whether E. coli grown in glucose + lactose medium expresses lac operon enzymes early or late. Glucose suppresses cAMP, so even though lactose is present the lac operon is OFF. Bacteria preferentially metabolise glucose first (diauxic growth — the classic Monod 1942 experiment). Only when glucose runs out and cAMP rises does the lac operon switch ON, and bacteria begin metabolising lactose. The switch shows visibly as a brief growth pause (the diauxic shift).

A common pitfall is to think gene regulation only happens at transcription. Another is to confuse operons (prokaryotic) with eukaryotic gene clusters (separate promoters).

See the gene expression lesson for lac operon and regulatory cascade diagrams.

Epigenetics and Gene Silencing

Epigenetics describes heritable expression states without DNA sequence changes. Two principal mechanisms:

DNA methylation at CpG dinucleotides (5-methylcytosine) → methyl-CpG-binding proteins recruit chromatin condensers → transcription silenced.

Histone modifications — acetylation by HAT (opens chromatin → activates) vs deacetylation by HDAC (closes chromatin → silences); methylation of specific lysines (H3K27me3 = silencing; H3K4me3 = activation).

Both are heritable across cell divisions but reversible — distinct from DNA mutations. X inactivation in mammalian females silences one X chromosome via XIST RNA + chromatin condensation, producing the Barr body.

Worked example. Explain the molecular basis of tortoiseshell cat coat patterns. The orange/black coat-colour gene is X-linked. Female cats are heterozygous. Each cell randomly silences one X chromosome via X inactivation; the silenced state is heritable through cell division. Daughter cells produce clones with the same silenced X. The result: a mosaic of orange patches (cells where the orange-bearing X is active) and black patches (cells where the black-bearing X is active). Male cats with one X cannot show this pattern unless they have an additional X chromosome (Klinefelter XXY).

A common pitfall is to think epigenetic changes alter DNA sequence. Another is to confuse methylation (silencing) with acetylation (activating).

See the epigenetics lesson for chromatin-state diagrams.

PCR and Gel Electrophoresis

Polymerase chain reaction (PCR) amplifies specific DNA sequences exponentially. One cycle: denature (95 °C) → anneal (50–65 °C, primers bind target sequences) → extend (72 °C, Taq polymerase from Thermus aquaticus extends primers). 30 cycles produces ~10⁹ copies from one template.

Gel electrophoresis separates DNA fragments by size in an agarose or polyacrylamide gel, with fragments migrating toward the positive electrode (DNA backbone is negatively charged); smaller fragments travel further.

Worked example. A PCR reaction uses primers flanking a 1,500 bp target. After 25 cycles, gel electrophoresis shows a strong 1,500 bp band as expected, plus an unexpected 800 bp band. Predict the cause and the diagnostic step. The 800 bp band is likely either a non-specific amplification (primers bound a similar sequence elsewhere) or a primer-dimer artefact. Diagnostic: BLAST the primer sequences against the genome to find off-target sites; lower the annealing temperature is unhelpful (would worsen specificity); raise the annealing temperature to suppress non-specific binding; or redesign primers to be more specific.

A common pitfall is to think Taq polymerase is a normal enzyme — it's heat-stable from a thermophile. Another is to think PCR amplifies any DNA — only sequences flanked by your primers.

See the PCR lesson for cycle diagrams.

Recombinant DNA and Genetic Engineering

Recombinant DNA combines DNA from two or more sources. The classic workflow for human insulin: (1) isolate insulin gene (cDNA from mRNA via reverse transcriptase); (2) cut both insulin gene and bacterial plasmid with the same restriction enzyme (matching sticky ends); (3) DNA ligase joins; (4) transform plasmid into bacterial host; (5) antibiotic selection isolates transformed cells; (6) culture in fermenter; (7) induce expression; (8) purify insulin protein. Yields kg quantities of human-identical insulin.

Restriction enzymes are bacterial defences against bacteriophages — they cut foreign DNA at specific sequences while the bacterium's own DNA is methylated for protection (the restriction-modification system).

Worked example. Predict why bacterial expression of eukaryotic genes typically uses cDNA, not genomic DNA. Eukaryotic genes contain introns; bacteria have no spliceosomes; transcription of genomic DNA in a bacterial host produces unspliced mRNA encoding a non-functional protein. cDNA (made from mRNA via reverse transcriptase) lacks introns — bacteria can translate it directly. The Eli Lilly recombinant insulin programme (1982) used this exact strategy.

A common pitfall is to confuse restriction enzymes (cut) with DNA ligase (join). Another is to miss why selection markers (antibiotic resistance) are needed — to grow only transformed cells.

See the recombinant DNA lesson for workflow diagrams.

Gene Therapy and Genetic Screening

Gene therapy introduces functional genes into a patient. Somatic therapy treats only the patient (changes not heritable; e.g. CAR-T cell therapy for leukaemia, beti-cel for β-thalassaemia, Casgevy 2023 for sickle-cell). Germline therapy alters egg, sperm, or embryo (heritable; e.g. He Jiankui's 2018 CRISPR-edited twins, internationally condemned).

Genetic screening: prenatal (chorionic villus sampling for cystic fibrosis, Huntington's); newborn (heel-prick for phenylketonuria); carrier (Tay-Sachs, sickle-cell); pre-implantation genetic diagnosis (PGD) during IVF.

Worked example. Predict why germline editing is more ethically contested than somatic therapy. Somatic therapy: only the patient is affected; consent is straightforward; if the therapy fails, only that patient suffers. Germline therapy: changes propagate to all descendants; future generations cannot consent; off-target effects could cause heritable harm; opens designer-baby and eugenics concerns; access asymmetry raises justice issues. The four-pillar bioethics framework (autonomy, beneficence, non-maleficence, justice) tilts strongly against germline at present — international moratoria in place since 2015.

A common pitfall is to confuse somatic and germline therapy. Another is to think gene therapy is universally experimental — multiple FDA-approved therapies exist now.

See the gene therapy lesson for somatic vs germline diagrams.

Genomics and Bioinformatics

Genomics sequences and analyses entire genomes. The Human Genome Project (1990–2003) used Sanger sequencing — ~$3 billion, ~13 years for 99$3billion, 13yearsfor991,000 per genome by 2014, ~$100 by 2023. Long-read sequencing (PacBio, Nanopore) resolves repetitive regions Illumina cannot.

Bioinformatics workflows: alignment (BWA, BLAST), variant calling (GATK), assembly (de novo), annotation. Pathogen-genome surveillance during outbreaks (SARS-CoV-2 lineage tracking) illustrates real-time application.

Worked example. Predict the consequence of dropping genome-sequencing cost from $1,000 to$1,000to100. Per-patient sequencing becomes economically feasible for routine clinical use — newborn whole-genome screening, personalised pharmacogenomics, precision oncology. The bottleneck shifts from sequencing technology to interpretation (what do all these variants mean clinically?) and to ethical/regulatory frameworks (privacy, insurance, incidental findings, parental consent for newborns).

A common pitfall is to think the genome is "the DNA" — it's the complete genetic material, ~3 billion bp + mitochondrial DNA, only ~2% protein-coding. Another is to confuse genome (DNA) with transcriptome (mRNA at one moment) with proteome (proteins present).

See the genomics lesson for sequencing-pipeline diagrams.

Ethics of Genetic Technology

The four-pillar bioethics framework (Beauchamp & Childress) provides structured ethical analysis: autonomy (informed consent), beneficence (do good), non-maleficence (do no harm), justice (equitable access).

Applied to CRISPR germline editing (the most contested current case): future children cannot consent (autonomy fails); claimed benefits are speculative vs known unknown harms (non-maleficence problematic); access asymmetry creates designer-baby concerns (justice fails). The 2018 He Jiankui twins were internationally condemned; international moratoria followed.

By contrast, somatic gene therapy passes all four pillars cleanly when supported by robust trials — the FDA-approved therapies for severe genetic diseases (Casgevy 2023, Luxturna, Zolgensma) exemplify ethically tractable applications.

Worked example. Apply the four-pillar framework to mandatory newborn whole-genome sequencing. Autonomy: parents consent on behalf of newborns who cannot, raising temporal-consent issues; what about incidental findings about adult-onset conditions? Beneficence: early diagnosis enables intervention for treatable conditions. Non-maleficence: false positives, anxiety, insurance discrimination, psychological harm to the child as they grow up knowing their genetic risks. Justice: cost asymmetry creates two-tier healthcare; some communities have historically been over- or under-sampled. The framework reveals that even apparently beneficial mass screening requires careful design, opt-out structures, and ongoing ethical oversight.

A common pitfall is to think ethics is "subjective" or "personal opinion" — it's a structured discipline with frameworks. Another is to confuse somatic and germline therapy ethically.

See the ethics lesson for four-pillar diagrams.

Common Mark-Loss Patterns

• Confusing gene with allele.
• Confusing template (antisense) and coding (sense) DNA strands.
• Thinking the 5' cap is added during transcription (it is) but the poly-A tail is encoded in the gene (it isn't — added post-transcriptionally).
• Confusing codon (mRNA) with anticodon (tRNA).
• Thinking gene regulation only happens at transcription.
• Confusing operons (prokaryotic) with eukaryotic gene clusters.
• Thinking epigenetic changes alter DNA sequence.
• Confusing methylation (silencing) with acetylation (activating).
• Confusing restriction enzymes with DNA ligase.
• Confusing somatic and germline gene therapy.
• Thinking the genome is "the DNA" rather than the complete genetic material.

How to Revise This Topic

• Master the central dogma (DNA → RNA → protein) end-to-end with one worked example.
• Drill the lac operon until both lactose and glucose inputs are automatic.
• Memorise epigenetic mechanisms — methylation vs acetylation, X inactivation, imprinting.
• Practice PCR calculations (cycles → fold amplification, primer design, troubleshooting).
• Build a recombinant-DNA flowchart for human insulin or hepatitis B vaccine production.
• Apply the four-pillar bioethics framework to germline editing, GM crops, and genetic screening — structure your ethics answers, don't just opine.
• Use the LearningBro Examiner Mode to drill 6-mark and 9-mark questions.

Linking to Other Topics

Modern Genetics is highly synoptic. Cells, viruses and reproduction provides the cellular machinery — ribosomes, nucleus, ER — where transcription and translation occur. Biological molecules supplies the chemistry of DNA, RNA, and proteins. Microbiology and pathogens returns to V(D)J recombination as the source of adaptive-immunity diversity, and to vaccine development using these same techniques. Biodiversity, evolution and natural resources uses molecular phylogenetics built on these same sequencing techniques. And the ethics framework applies across all biotechnology — from agricultural GM to pandemic preparedness.

Final Word

Modern Genetics is one of the most contemporary topics on 9BI0 — recent CRISPR developments, COVID mRNA vaccines, falling sequencing costs, and rising AMR all draw on this material. Drill the central dogma, master the lac operon, memorise epigenetic mechanisms, and practice ethical reasoning until it feels structured rather than intuitive. The full LearningBro Modern Genetics, Gene Technology and Genomics course walks through every sub-topic with diagrams, worked examples, AI tutor feedback, and Examiner Mode marking. Get this section right and the molecular vocabulary you build here will support most of Paper 2 and many Paper 3 synoptic questions.